Overview
- Psilocybin use among U.S. adults surpassed cocaine, illicit opioids, methamphetamine, and LSD in 2023, with consumption up 188% among those 30 and older since 2019.
- Adolescents and young adults have also shown significant increases, with use among 12th graders rising 53% over the same period.
- Reports of psilocybin-related exposures to poison control centers jumped 201% in adults, 317% in adolescents, and 723% in children between 2019 and 2023.
- Experts emphasize the need for supervised use as unsupervised consumption has led to adverse psychological and medical incidents, including cardiovascular risks and hospitalizations.
- Decriminalization in cities like Denver and states such as Oregon has fueled accessibility, but most psilocybin use remains recreational rather than therapeutic despite its potential mental health benefits.